Safety of intraparenchymal injection of allogenic placenta mesenchymal stem cells derived exosome in patients undergoing decompressive craniectomy following malignant middle cerebral artery infarct, a pilot randomized clinical trial-Reference-Cited by-同舟云学术

Safety of intraparenchymal injection of allogenic placenta mesenchymal stem cells derived exosome in patients undergoing decompressive craniectomy following malignant middle cerebral artery infarct, a pilot randomized clinical trial

Published:2022 Issue:1 Volume:13 Page:7
ISSN:2008-7802
Container-title:International Journal of Preventive Medicine
language:en
Short-container-title:Int J Prev Med

Author:

Khojasteh Arash,Oraee-Yazdani Saeed,Dehghani Leila,Soleimani Masoud,Keshel SaeedHeidari,Saadatnia Mohammad,Saboori Masih,Zali Alireza,Hashemi SeyedMahmoud,Soleimani Reyhane

Publisher

Medknow

Subject

Public Health, Environmental and Occupational Health

Reference25 articles.

1. Malignant Middle cerebral artery (MCA) infarction: Pathophysiology, diagnosis and management;Treadwell;Postgrad Med J,2010

2. 10-year institutional retrospective case series of decompressive craniectomy for malignant middle cerebral artery infarction (mMCAI);Lammy;World Neurosurg,2016

3. Hemicraniectomy in the management of malignant middle cerebral artery infarction: Lessons from randomized, controlled trials;Hatefi;Surg Neurol Int,2014

4. Early decompressive surgery in malignant infarction of the middle cerebral artery: A pooled analysis of three randomised controlled trials;Vahedi;Lancet Neurol,2007

5. Hemicraniectomy for massive middle cerebral artery territory infarction: A systematic review;Gupta;Stroke,2004

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering therapeutical extracellular vesicles for clinical translation;Trends in Biotechnology;2024-09

2. Efficacy and safety of mesenchymal stem cell therapies for ischemic stroke: a systematic review and meta-analysis;Stem Cells Translational Medicine;2024-08-19

3. Mesenchymal stromal/stem cell tissue source and in vitro expansion impact extracellular vesicle protein and miRNA compositions as well as angiogenic and immunomodulatory capacities;Journal of Extracellular Vesicles;2024-08

4. A systematic review and meta‐analysis of clinical trials assessing safety and efficacy of human extracellular vesicle‐based therapy;Journal of Extracellular Vesicles;2024-07

5. An Overview on the Physiopathology of the Blood–Brain Barrier and the Lipid-Based Nanocarriers for Central Nervous System Delivery;Pharmaceutics;2024-06-22